NIFTY 50▼21,957.50
-345.00 (-1.55%)
SENSEX▼72,404.17
-1062.22 (-1.45%)
NIFTY BANK▼47,487.90
-533.20 (-1.11%)
TATA MOTORS▲1,030.30
18.20 (1.80%)
INDIAN RAILWAY FINANCE CORP▼147.05
-5.20 (-3.42%)
TATA POWER▼413.50
-21.55 (-4.95%)
TATA STEEL▼161.90
-4.15 (-2.50%)
SUZLON ENERGY▼39.60
-0.35 (-0.88%)
YES BANK▼22.60
-0.35 (-1.53%)
INDIAN RENEWABLE ENERGY▼164.80
-6.10 (-3.57%)
RELIANCE INDUSTRIES▼2,788.25
-48.85 (-1.72%)
VODAFONE IDEA▼12.65
-0.05 (-0.39%)
RELIANCE POWER▼24.75
-1.00 (-3.88%)
JIO FIN SERVICES LTD▼345.40
-9.80 (-2.76%)
HDFC BANK▼1,447.50
-35.15 (-2.37%)
RAIL VIKAS NIGAM▼261.05
-8.90 (-3.30%)
ADANI POWER▲612.80
32.15 (5.54%)
ZOMATO▼195.25
-0.20 (-0.10%)
NHPC▼93.65
-5.20 (-5.26%)
STATE BANK OF INDIA▲819.80
9.00 (1.11%)
INDIAN OIL CORP▼156.60
-6.55 (-4.01%)
INDIAN RAILWAY TOURISM CORP▼986.10
-21.35 (-2.12%)
MRF▼1,26,225.15
-452.50 (-0.36%)
ITC▼425.10
-15.90 (-3.61%)
JAIPRAKASH POWER VENTURES▼17.85
-0.75 (-4.03%)
ADANI GREEN ENERGY▼1,712.15
-60.85 (-3.43%)
ADANI PORT & SEZ▼1,244.55
-32.70 (-2.56%)
ADANI ENTERPRISES▼2,766.65
-93.90 (-3.28%)
- Concord Biotech
34% Hold
Concord Biotech Share Price
CONCORDBIO
₹1,501.30-₹51.90 (-3.34%) TodayLast updated on 09 May, 2024 | 03:46 PM IST
₹1,491.40₹1,567.35
LH
What’s in news?
Company overview
About
Market cap
| Open₹1,550.00 | Close₹1,553.20 |
Circuit range₹1,863.80 - ₹1,242.60 | Day range₹1,491.40 - ₹1,567.35 | Year range₹900.05 - ₹1,725.00 |
Volume30,416 | Avg. traded₹1,518.79 | Revenue (12m)₹971 Cr |
Concord BiotechConcord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic processes and finished formulations. It manufactures fermentation and semi-synthetic based products in the therapeutic segments, such as immunosuppressants, anti-bacterial, oncology, anti-fungal and others. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Vancomycin Hydrochloride, Micafungin Sodium, Mupirocin, Romidepsin, Dactinomycin, and Pravastatin Sodium, among others. It also has a pipeline of API products under development. Its API products under development include Polymyxin B, Fidaxomicin, Doxorubicin, and others. The Company provides products in the critical care, immunology, nephrology, and transplant medicine segments.
Read more
Concord Biotech Key indicators
52 week high₹1,725.00 | 52 week low₹900.05 | P/E ratio54.01 |
P/B ratio11.36 | ROE19.85% | ROCE26.48% |
Dividend yield0.44% | Debt/Equity ratio0.02 | EPS22.76 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Hold
Analyst ratings:
Hold33%
Hold
34%
Sell
33%
This analysis is based on the reviews of 3 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin45% | Net profit margin27.91% |
ROE19.85% | ROA14.87% |
ROCE26.48% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Concord Biotech Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Wed, May 8 2024 | ₹1,557.00 | ₹1,553.20 | -0.24% |
Tue, May 7 2024 | ₹1,563.00 | ₹1,557.05 | -0.38% |
Mon, May 6 2024 | ₹1,641.00 | ₹1,578.55 | -3.96% |
Fri, May 3 2024 | ₹1,655.00 | ₹1,617.75 | -2.30% |
Thu, May 2 2024 | ₹1,661.35 | ₹1,658.90 | -0.15% |
Tue, Apr 30 2024 | ₹1,655.00 | ₹1,667.10 | |
Mon, Apr 29 2024 | ₹1,684.50 | ₹1,650.45 | -2.06% |
Fri, Apr 26 2024 | ₹1,649.90 | ₹1,660.05 |
Events
No data available at the moment
More
Similar stocks
No data available at the moment
People also bought
No data available at the moment